Histologic grade and cellular proliferation at the deepest invasive portion correlate with the high malignancy of submucosal invasive gastric carcinoma
- PMID: 7777250
- DOI: 10.1159/000227486
Histologic grade and cellular proliferation at the deepest invasive portion correlate with the high malignancy of submucosal invasive gastric carcinoma
Abstract
To establish appropriate indications for endoscopic treatment of submucosal invasive gastric carcinoma, we investigated clinicopathologic features and proliferating cell nuclear antigen (PCNA) expression at the deepest invasive portion of 192 differentiated submucosal invasive gastric carcinomas that had been surgically resected. Lymph node metastasis was demonstrated in 30 (15.6%) of 192 lesions. Histologic heterogeneity (based on differentiation at the deepest invasive portion) was demonstrated in 36 (18.8%) of the 192 lesions. In 159 lesions, excluding 33 undifferentiated lesions at the deepest invasive portion, the depth of invasion, histologic grade, lymph vessel involvement, infiltrative growth pattern (INF) and existence of an ulceration were all significantly correlated with the incidence of lymph node metastasis. The lesions with both well-differentiated adenocarcinoma (WELL) and minimal submucosal invasion (sm1) showed no lymph node metastasis. PCNA expression was estimated in 59 good stained lesions. The mean PCNA labeling index (LI) was 50.9 +/- 7.2% in lesions with lymph node metastasis and 43.7 +/- 9.3% in those without lymph node metastasis (p < 0.05). In addition, PCNA-LI also correlated significantly with the histologic grade, depth of invasion, INF and lymph vessel involvement. These results indicate that the submucosal invasive gastric carcinoma with both WELL and sm1, which shows no other risk factors, can be considered as the appropriate indication for curative endoscopic treatment. The PCNA-LI at the deepest invasive portion is useful in understanding the biology of lymph node metastasis in submucosal invasive gastric carcinoma.
Similar articles
-
Proliferating cell nuclear antigen expression correlates with the metastatic potential of submucosal invasive colorectal carcinoma.Oncology. 1995 Mar-Apr;52(2):134-9. doi: 10.1159/000227444. Oncology. 1995. PMID: 7854773
-
Immunoreactive MUC1 expression at the deepest invasive portion correlates with prognosis of colorectal cancer.Oncology. 1998 Jul-Aug;55(4):307-19. doi: 10.1159/000011868. Oncology. 1998. PMID: 9663420
-
Mixed-histologic-type submucosal invasive gastric cancer as a risk factor for lymph node metastasis: feasibility of endoscopic submucosal dissection.Endoscopy. 2009 May;41(5):427-32. doi: 10.1055/s-0029-1214495. Epub 2009 May 5. Endoscopy. 2009. PMID: 19418397
-
[The risk factors of lymph node metastasis in submucosal invasive gastric carcinoma--assessment of the indication for endoscopic treatment].Nihon Shokakibyo Gakkai Zasshi. 1994 Sep;91(9):1399-406. Nihon Shokakibyo Gakkai Zasshi. 1994. PMID: 7933637 Japanese.
-
The biologic features of intramucosal gastric carcinoma with lymph node metastasis.Surgery. 2002 Jan;131(1 Suppl):S71-7. doi: 10.1067/msy.2002.119307. Surgery. 2002. PMID: 11821790 Review.
Cited by
-
Pathological tumor infiltrative pattern and sites of initial recurrence in stage II/III gastric cancer: Propensity score matching analysis of a multi-institutional dataset.Cancer Med. 2018 Dec;7(12):6020-6029. doi: 10.1002/cam4.1868. Epub 2018 Nov 8. Cancer Med. 2018. PMID: 30411544 Free PMC article.
-
Clinical significance of a papillary adenocarcinoma component in early gastric cancer: a single-center retrospective analysis of 628 surgically resected early gastric cancers.J Gastroenterol. 2015 Apr;50(4):424-34. doi: 10.1007/s00535-014-0991-6. Epub 2014 Aug 21. J Gastroenterol. 2015. PMID: 25142800
-
Continued use of low-dose aspirin does not increase the risk of bleeding during or after endoscopic submucosal dissection for early gastric cancer.Gastric Cancer. 2014;17(3):489-96. doi: 10.1007/s10120-013-0305-3. Epub 2013 Oct 19. Gastric Cancer. 2014. PMID: 24142107 Free PMC article.
-
Clinical validity of endoscopic submucosal dissection for submucosal invasive gastric cancer: a single-center study.Gastric Cancer. 2012 Jan;15(1):97-105. doi: 10.1007/s10120-011-0076-7. Epub 2011 Jul 23. Gastric Cancer. 2012. PMID: 21785925
-
Risk factors for lymphatic and venous involvement in endoscopically resected gastric cancer.J Gastroenterol. 2013 Jun;48(6):706-12. doi: 10.1007/s00535-012-0696-7. Epub 2012 Oct 24. J Gastroenterol. 2013. PMID: 23090003
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous